TNFSF14 and neoplasm: LTG-mediated FoxO3a re-expression was accompanied by a strong reduction of tumor mass in TamR-derived mouse xenograft, suggesting how LTG might represent a valid candidate in combination therapy to prevent resistance to tamoxifen in BC treatment [110] (Figure 2).